1. Inhibition of Src Tyrosine Kinase Impairs Inherent and Acquired Gemcitabine Resistance in Human Pancreatic Adenocarcinoma Cells
   Mark S. Duxbury et al, 2004, Clinical Cancer Research CrossRef
2. Vascular Endothelial Growth Factor-Trap Suppresses Tumorigenicity of Multiple Pancreatic Cancer Cell Lines
   Mitsuharu Fukasawa et al, 2004, Clinical Cancer Research CrossRef
3. KAI1 is a potential target for anti-metastasis in pancreatic cancer cells
   Jian-Hua Xu et al, 2008, World Journal of Gastroenterology CrossRef
4. Pre-clinical Models of Metastasis in Pancreatic Cancer
   Maria Miquel et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
5. Galectin-3 is modulated in pancreatic cancer cells under hypoxia and nutrient deprivation
   Antônio F. da Silva Filho et al, 2020, Biological Chemistry CrossRef
6. Morphofunctional analysis of human pancreatic cancer cell lines in 2- and 3-dimensional cultures
   Fuuka Minami et al, 2021, Scientific Reports CrossRef
7. Functional CDKN2A assay identifies frequent deleterious alleles misclassified as variants of uncertain significance
   Hirokazu Kimura et al, 2022, eLife CrossRef
8. Identifying Allelic Loss and Homozygous Deletions in Pancreatic Cancer without Matched Normals Using High-Density Single-Nucleotide Polymorphism Arrays
   Eric S. Calhoun et al, 2006, Cancer Research CrossRef
9. Unraveling altered RNA metabolism in pancreatic cancer cells by liquid-chromatography coupling to ion mobility mass spectrometry
   Simon Lagies et al, 2019, Analytical and Bioanalytical Chemistry CrossRef
10. Targeting autophagy in pancreatic cancer: The cancer stem cell perspective
    Dimitrios Troumpoukis et al, 2022, Frontiers in Oncology CrossRef
11. Major histocompatibility complex class I molecule expression by pancreatic cancer cells is regulated by activation and inhibition of the epidermal growth factor receptor
    Shelby M. Knoche et al, 2022, Immunologic Research CrossRef